Cochrane Abstracts
Dapagliflozin for adults with type 2 diabetes mellitus
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Dapagliflozin for Adults With Type 2 Diabetes Mellitus." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434973/all/Dapagliflozin_for_adults_with_type_2_diabetes_mellitus.
Dapagliflozin for adults with type 2 diabetes mellitus. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434973/all/Dapagliflozin_for_adults_with_type_2_diabetes_mellitus. Accessed April 30, 2025.
Dapagliflozin for adults with type 2 diabetes mellitus. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434973/all/Dapagliflozin_for_adults_with_type_2_diabetes_mellitus
Dapagliflozin for Adults With Type 2 Diabetes Mellitus [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 April 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434973/all/Dapagliflozin_for_adults_with_type_2_diabetes_mellitus.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Dapagliflozin for adults with type 2 diabetes mellitus
ID - 434973
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434973/all/Dapagliflozin_for_adults_with_type_2_diabetes_mellitus
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
